---
title: Tenecteplase for Ischemic Stroke at 4.5 to 24 Hours without Thrombectomy
date: '2024-06-17'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38884324/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&fc=20211015124055&ff=20240618181202&v=2.18.0.post9+e462414
source: N Engl J Med
description: 'CONCLUSIONS: In this trial involving Chinese patients with ischemic
  stroke due to large-vessel occlusion, most of whom did not undergo endovascular
  thrombectomy, treatment with tenecteplase administered within 4.5 to 24 hours after
  stroke onset resulted in less disability and similar survival as compared with standard
  medical treatment, and the incidence of symptomatic intracranial hemorrhage appeared
  to be higher. (Funded by the National Natural Science Foundation of China and others;
  ...'
disable_comments: true
---
CONCLUSIONS: In this trial involving Chinese patients with ischemic stroke due to large-vessel occlusion, most of whom did not undergo endovascular thrombectomy, treatment with tenecteplase administered within 4.5 to 24 hours after stroke onset resulted in less disability and similar survival as compared with standard medical treatment, and the incidence of symptomatic intracranial hemorrhage appeared to be higher. (Funded by the National Natural Science Foundation of China and others; ...